Insmed, Inc. (INSM)
94.98
+0.76
(+0.81%)
USD |
NASDAQ |
Jun 08, 13:39
Insmed EPS Diluted (Quarterly) : -0.7591 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -3.251 |
| United Therapeutics Corp. | 5.824 |
| PTC Therapeutics, Inc. | -0.034 |
| Protagonist Therapeutics, Inc. | 0.0537 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -163.56M |
| Revenue (Quarterly) | 305.96M |
| Total Expenses (Quarterly) | 469.53M |
| Enterprise Value | 19.93B |
| Gross Profit Margin (Quarterly) | 83.82% |
| Profit Margin (Quarterly) | -53.46% |
| Earnings Yield | -6.05% |
| Normalized Earnings Yield | -5.372 |